CHUV
Les activités du CHUV
MENU
Centre de la prostate
Accueil > Recherche > Publications > Publications 2014

Publications de l'année 2014


The aging male: a global approach to late onset hypogonadism and erectile dysfunction.

Vlamopoulos Y, Jichlinski P, Tawadros T.

Rev Med Suisse. 2014 Dec 3;10(453):2328-31. Review. French.

PMID:25626250

Focal therapy in prostate cancer: rationale, results and perspectives.

Valerio M, Benamran D, Tawadros T, Cerantola Y, Meuwly JY, Lutchmaya-Flick C, Lhermitte B, Wirth G, Iselin C, Jichlinski P.

Rev Med Suisse. 2014 Dec 3;10(453):2306-10. Review. French.

PMID:25626246

Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer.

Brown M, Roulson JA, Hart CA, Tawadros T, Clarke NW.

Br J Cancer. 2014 Apr 15;110(8):2099-108. doi: 10.1038/bjc.2014.99. Epub 2014 Mar 4.

PMID:24595005

The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO--Young Members Working Group (AIRO Giovani).

Franco P, De Bari B, Ciammella P, Fiorentino A, Chiesa S, Amelio D, Pinzi V, Bonomo P, Vagge S, Fiore M, Comito T, Cecconi A, Mortellaro G, Bruni A, Trovò M, Filippi AR, Greto D, Alongi F; AIRO Giovani Italian Association of Radiation Oncology, Young Members Working Group.

Tumori. 2014 Nov-Dec;100(6):e214-9. doi: 10.1700/1778.19280.

PMID:25688503

Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: a potential comparison bias.

Arcangeli S, De Bari B, Alongi F.

J Clin Oncol. 2014 Oct 20;32(30):3454. doi: 10.1200/JCO.2014.56.3213. Epub 2014 Sep 2. No abstract available.

PMID:25185086

Choline-PET in prostate cancer management: the point of view of the radiation oncologist.

De Bari B, Alongi F, Lestrade L, Giammarile F.

Crit Rev Oncol Hematol. 2014 Sep;91(3):234-47. doi: 10.1016/j.critrevonc.2014.04.002. Epub 2014 Apr 28. Review.

PMID:24813466

Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.

Pegurri L, Buglione M, Girelli G, Guarnieri A, Meattini I, Ricardi U, Mangoni M, Gabriele P, Bellavita R, Krengli M, Bonetta A, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Gatta R, De Bari B, Magrini SM.

Tumori. 2014 Jan-Feb;100(1):31-7. doi: 10.1700/1430.15812.

PMID:24675488

From radiobiology to technology: what is changing in radiotherapy for prostate cancer.

De Bari B, Fiorentino A, Arcangeli S, Franco P, D'Angelillo RM, Alongi F.

Expert Rev Anticancer Ther. 2014 May;14(5):553-64. doi: 10.1586/14737140.2014.883282. Epub 2014 Mar 3. Review.

PMID:24579695

Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.

De Bari B, Alongi F, Buglione M, Campostrini F, Briganti A, Berardi G, Petralia G, Bellomi M, Chiti A, Fodor A, Suardi N, Cozzarini C, Nadia DM, Scorsetti M, Orecchia R, Montorsi F, Bertoni F, Magrini SM, Jereczek-Fossa BA.

Crit Rev Oncol Hematol. 2014 Apr;90(1):24-35. doi: 10.1016/j.critrevonc.2013.11.003. Epub 2013 Nov 21. Review.

PMID:24315428

Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.

Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU.

Eur Urol. 2014 Nov 1. pii: S0302-2838(14)01040-9. doi: 10.1016/j.eururo.2014.10.026. [Epub ahead of print] Review.

PMID:25454618

Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.

Valerio M, Cerantola Y, Fritschi U, Hubner M, Iglesias K, Legris AS, Lucca I, Vlamopoulos Y, Vaucher L, Jichlinski P.

Can Urol Assoc J. 2014 Sep;8(9-10):E600-4. doi: 10.5489/cuaj.1848.

PMID:25295129

Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.

Valerio M, Stricker PD, Ahmed HU, Dickinson L, Ponsky L, Shnier R, Allen C, Emberton M.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):343-7. doi: 10.1038/pcan.2014.33. Epub 2014 Sep 2.

PMID:25179590

Re: Jarow et al.: Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop (Urology 2014;83:975-979).

Valerio M, Emberton M, Ahmed HU.

Urology. 2014 Sep;84(3):732-3. doi: 10.1016/j.urology.2014.06.007. No abstract available.

PMID:25168560

Focal therapy will become a standard option for selected men with localized prostate cancer.

Valerio M, Emberton M, Ahmed HU.

J Clin Oncol. 2014 Nov 10;32(32):3680-1. doi: 10.1200/JCO.2014.56.7792. Epub 2014 Aug 18. No abstract available.

PMID:25135989

A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).

Valerio M, Dickinson L, Ali A, Ramachandran N, Donaldson I, Freeman A, Ahmed HU, Emberton M.

Contemp Clin Trials. 2014 Sep;39(1):57-65. doi: 10.1016/j.cct.2014.07.006. Epub 2014 Jul 26.

PMID:25072507

Re: Tumor target volume for focal therapy of prostate cancer--does multiparametric magnetic resonance imaging allow for a reliable estimation?: F. Cornud, G. Khoury, N. Bouazza, F. Beuvon, M. Peyromaure, T. Flam, M. Zerbib, P. Legmann and N. B. Delongchamps. J Urol 2014; 191: 1272-1279.

Valerio M, Ahmed HU.

J Urol. 2014 Oct;192(4):1297-8. doi: 10.1016/j.juro.2014.04.102. Epub 2014 Jul 11. No abstract available.

PMID:25020240

Health technology assessment in evolution - focal therapy in localised prostate cancer.

Valerio M, Emberton M, Barret E, Eberli D, Eggener SE, Ehdaie B, Jichlinski P, Ward JF, Ahmed HU.

Expert Rev Anticancer Ther. 2014 Nov;14(11):1359-67. doi: 10.1586/14737140.2014.932692. Epub 2014 Jun 25.

PMID:24965212

Defining the level of evidence for technology adoption in the localized prostate cancer pathway.

Valerio M, El-Shater Bosaily A, Emberton M, Ahmed HU.

Urol Oncol. 2014 Aug;32(6):924-30. doi: 10.1016/j.urolonc.2013.10.008. Epub 2013 Dec 12.

PMID:24332638

The role of focal therapy in the management of localised prostate cancer: a systematic review.

Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, Nguyen PL, Trachtenberg J, Polascik TJ.

Eur Urol. 2014 Oct;66(4):732-51. doi: 10.1016/j.eururo.2013.05.048. Epub 2013 Jun 6.

PMID:23769825

Urology.

Jichlinski P.

Rev Med Suisse. 2014 Jan 15;10(412-413):127-9. Review. French.

PMID:24558917